Pick your metaphor….” For health tech, it was the best H1 since H1 2022, with $7.2 billion versus $9.1 billion in investment, a tidy increase versus 2025 H1’s $6.7 billion. The major difference is ...
Cityblock simultaneously announced a Series E of $116 million led by General Catalyst for a total of close to $1 billion. General Catalyst is an investor in both companies. (Is this a return to the ...
The cost of Oracle’s extended EHRM contract with the Department of Veterans Affairs disclosed. The ten-year contract for the ...
The number of hospitals impacted by EHR purchase decisions dropped 40% compared to 2024 and nearly 50% compared to 2023. Acute care EHR purchase energy declined significantly in 2025, driven by ...
While SpaceX has debuted to well over a $2.3 trillion (that’s with a T) market cap, it seems that even giant companies are still facing expensive headwinds. To Reuters and to Business Insider, an ...
In the Chutes department, it’s an insurer breach and an AI model that broke dramatically out of its sandbox.
Mr. Market woke up out of his summertime nap with some surprising end-of-July activity. What will August bring?
This says it all for startups and early stage companies in the healthcare tech field. We feature today Haverin Consulting’s Stuart Miller, continuing his analysis of the signs that a health tech ...
The hottest doctor reference source withdrew its medical evidence and decision support app from the UK and European markets. The news, reported in HIStalk on 28 April, is shocking–but not surprising.
A bad wake up this morning for too many people. To absolutely no one’s surprise to close out this month, including Mr. Market (right), Oracle Corporation laid off an estimated 20-30,000 staff globally ...
Perhaps the rabbit is being pulled from the top hat. Or it’s hungry. Three recent announcements are giving Oracle shareholders–of which founder Larry Ellison is a 40% holder–some confidence in a ...
The long Masimo drama has a Hollywood Ending, at least for shareholders. The sale announced on Tuesday 17 February is a rich one–$180 per share, cash. (Masimo was trading in the ~$130/share range last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results